# The Impact of Weight Loss Secondary to Bariatric Surgery on Telomere Biology: A Narrative Review

**Authors:** Saleha Khan, Husna Irfan Thalib, Sariya Khan, Yara Osama Aldawood, Dahlia Mirdad, Abdulrahman Alotaibi, Wisam Jamal, Haneen Alnazzawi, Wed Salah, Abeer Zakariyah

PMC · DOI: 10.3390/biomedicines14020417 · Biomedicines · 2026-02-12

## TL;DR

This review explores how weight loss from bariatric surgery may affect telomere biology, potentially slowing aging-related effects linked to obesity.

## Contribution

The paper provides a narrative review of how bariatric surgery influences telomere biology, addressing controversies and methodological challenges.

## Key findings

- Bariatric surgery is associated with reduced telomere attrition in some studies.
- Oxidative stress from obesity accelerates telomere shortening.
- Methodological inconsistencies in TL measurement remain a challenge in the field.

## Abstract

The global escalation in chronic obesity and its associated comorbidities has emerged as a substantial public health and economic challenge. This crisis is further compounded by the genomic impact of obesity on telomere length (TL), primarily driven by unchecked oxidative stress. As a result, telomeres shorten, leading to the onset of age-related disorders. In response, effective therapeutic interventions, notably bariatric surgery (BS), have demonstrated significant improvements in patient outcomes by reducing morbidity and mortality rates. Contemporary research has expanded on these benefits, investigating the impact of weight reduction on TL. While the majority of studies support the attenuation of telomeric attrition, ongoing debates surrounding methodological limitations and conflicting results underscore the need for further investigation. This narrative review outlines the current research on the mechanisms that influence telomeres, with a focus on the methodologies used to measure TL. Furthermore, we will examine the most recent findings on the effects of weight loss resulting from surgical intervention on telomere biology. This analysis aims to address specific controversies surrounding this topic and provide evidence-based recommendations valuable to the healthcare sector for mitigating obesity, as well as educating patients about the molecular-level effects of weight reduction resulting from surgical procedures, to enable informed consent.

## Linked entities

- **Diseases:** obesity (MONDO:0011122)

## Full-text entities

- **Genes:** CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TERT (telomerase reverse transcriptase) [NCBI Gene 7015] {aka CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, TERF2 (telomeric repeat binding factor 2) [NCBI Gene 7014] {aka TRBF2, TRF2}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, TERC (telomerase RNA component) [NCBI Gene 7012] {aka DKCA1, PFBMFT2, SCARNA19, TER, TR, TRC3}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, TPP1 (tripeptidyl peptidase 1) [NCBI Gene 1200] {aka CLN2, GIG1, LPIC, SCAR7, TPP-1}, TERF1 (telomeric repeat binding factor 1) [NCBI Gene 7013] {aka PIN2, TRBF1, TRF, TRF1, hTRF1-AS, t-TRF1}, FGB (fibrinogen beta chain) [NCBI Gene 2244] {aka HEL-S-78p}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, POT1 (protection of telomeres 1) [NCBI Gene 25913] {aka CMM10, CRMCC3, GLM9, HPOT1, PFBMFT8, TPDS3}, TINF2 (TERF1 interacting nuclear factor 2) [NCBI Gene 26277] {aka DKCA3, DKCA5, TIN2}, TERF2IP (TERF2 interacting protein) [NCBI Gene 54386] {aka DRIP5, RAP1}
- **Diseases:** respiratory and digestive disorders (MESH:D004066), insulin resistance (MESH:D007333), age- (MESH:D019588), Weight Loss (MESH:D015431), cardiovascular disease (MESH:D002318), infections (MESH:D007239), nutritional deficiencies (MESH:D044342), BS (MESH:D000267), hypertension (MESH:D006973), sleep apnea (MESH:D012891), glucose intolerance (MESH:D018149), immune dysregulation (OMIM:614878), TL (MESH:C536801), appetite suppression (MESH:D001068), adiposity (MESH:D018205), type 2 diabetes (MESH:D003924), obstructive sleep apnea (MESH:D020181), impaired glucose metabolism (MESH:D044882), cancers (MESH:D009369), diabetes (MESH:D003920), Oxidative (MESH:D028361), MetS (MESH:D024821), Chronic systemic inflammation (MESH:D007249), injury to (MESH:D014947), diseases (MESH:D004194), hematopoietic neoplasms (MESH:D019337), Metabolic Health (MESH:D008659), arthritic conditions (MESH:D015535), inherited telomere disorders (MESH:D030342), overweight (MESH:D050177), Obesity (MESH:D009765)
- **Chemicals:** 8-dihydro-2'-deoxyguanosine (-), heavy metals (MESH:D019216), glucose (MESH:D005947), alcohol (MESH:D000438), Lipid (MESH:D008055), polyphenols (MESH:D059808), guanine (MESH:D006147), triglycerides (MESH:D014280), cortisol (MESH:D006854), omega-3 fatty acids (MESH:D015525), saline (MESH:D012965), blood glucose (MESH:D001786), cholesterol (MESH:D002784), 8-oxodG (MESH:D000080242), silicone (MESH:D012828), FFA (MESH:D005230)
- **Species:** Homo sapiens (human, species) [taxon 9606], Musa acuminata (banana, species) [taxon 4641]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938474/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938474/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938474/full.md

---
Source: https://tomesphere.com/paper/PMC12938474